Five minutes with…Takanori Abe, Abe & Partners

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Five minutes with…Takanori Abe, Abe & Partners

Takanori.jpg

Each week Managing IP speaks to a different IP practitioner about their life and career

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about IP practitioners on a personal as well as a professional level. This time we have Takanori Abe, managing partner at Abe & Partners in Osaka

Someone asks you at a party what you do for a living. What do you say?

I help protect “what is important but invisible”.

Talk us through a typical working day.

Morning: coffee accompanied by Mozart’s 'Requiem' by Herbert von Karajan.

Afternoon: tea with Bach’s 'Goldberg Variations' by Glenn Gould.

Night: red wine with Chopin's 'Piano Concerto No.1' by Nobuyuki Tsujii.

All the way through, I am thinking about how to win my cases. In my dreams, I talk with the judge.

What are you working on at the moment?

I am representing large global pharmaceutical companies across various pharma patent cases. This includes infringement cases between two originating companies, an originator and a biosimilar, and originators and generics. I am also managing invalidation and opposition proceedings at the JPO.

Meanwhile, I am also advising multinational and domestic clients on fair, reasonable, and non-discriminatory matters for standard-essential patents.

Does one big piece of work usually take priority or are you juggling multiple things?

I am required to multi-task like an astronaut.

What is the most exciting aspect of your role and what is the most stressful?

Seeing a client’s smiling face when we have won a case and shaking hands with them is the most exciting. Seeing their sad face when we have lost is the most stressful.

Tell us the key characteristics that make a successful IP lawyer/practitioner.

Eagerness to draw a new map.

What is the most common misconception about IP?

Criticism from bioethics that IP benefits only the wealthy.

What or who inspires you?

Susumu Tonegawa, the 1987 Nobel Prize winner for physiology or medicine. He clarified the genetic mechanism of the adaptive immune system, which had been the central question of immunology for more than 100 years.

If you weren't in IP, what would you be doing?

I’d like to be a molecular biologist.

Any advice you would give your younger self?

None.

more from across site and SHARED ros bottom lb

More from across our site

News of EasyGroup failing in its trademark infringement claim against ‘Easihire’ and Amgen winning a key appeal at the UPC were also among the top talking points
Submit your nominations to this year's WIBL EMEA Awards by February 16 2026
Edward Russavage and Maria Crusey at Wolf Greenfield say that OpenAI MDL could broaden discovery and reshape how clients navigate AI copyright disputes
The UPC has increased some fees by as much as 32%, but firms and their clients had been getting a good deal so far
Meryl Koh, equity director and litigator at Drew & Napier in Singapore, discusses an uptick in cross-border litigation and why collaboration across practice areas is becoming crucial
The firm says new role will be at the forefront of how it delivers value and will help bridge the gap between lawyers, clients and tech
Qantm IP’s CEO and AI programme lead discuss the business’s investment and M&A plans, and reveal their tech ambitions
Controversial plans were scrapped by the Commission earlier this year after the Parliament had previously backed them
Lawyers at Spoor & Fisher provide an overview of how South Africa is navigating copyright and consent requirements to improve access to works for blind and visually impaired people
Gillian Tan explains how she balances TM portfolio management with fast-moving deals, and why ‘CCP’ is a good acronym to live by
Gift this article